Springer Nature AG & Co. KGaA

Springer Nature AG & Co. KGaA

20.75
EUR
-0.05
(-0.24%)
3.77BMarket Cap
Mar 23Next Earn
Springer Nature AG & Co. KGaA
MUN:SPG
(Munich Stock Exchange)

Recent

price

20.75

P/E

ratio

- -

div

yld

- -

ROIC.AI

2013
2014
2015
2016
2017
2023
2024
2025
TTM
EUR
- -
3.17
4.85
5.36
5.4
9.75
9.29
9.69
- -
Revenue per Share
- -
-0.74
-0.47
-0.4
-0.23
0.08
0.34
1.79
- -
Basic EPS, GAAP
- -
0.94
0.99
1.18
1.3
2.35
2.46
2.62
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
0.01
- -
- -
0.13
- -
Dividend per Share
0.95
0.25
1.4
0.29
-0.28
0.18
9.1
10.19
10.05
Book Value per Share
-12.3
-13
-16.76
-17.05
-16.21
-21.32
-12.43
-9.96
-10.11
Tangible Book Value per Share
303
303
303
303
303
190
199
199
199
Basic Weighted Avg Shares
- -
959
1,471
1,625
1,637
1,853
1,847
1,926
- -
Sales/Revenue/Turnover
- -
14.09
10.98
14.96
14.71
21.89
21.89
24.02
- -
Operating Margin (%)
- -
257
260
270
387
277
284
265
- -
Depreciation Expense
- -
-224
-142
-122
-68
16
68
356
- -
Net Income, GAAP
- -
- -
- -
- -
- -
78.78
60.58
11.71
- -
Effective Tax Rate (%)
- -
-23.36
-9.63
-7.54
-4.17
0.84
3.7
18.46
- -
Profit Margin (%)
-213
-224
-208
-194
-86
-184
34
51
-69
Working Capital
2,771
2,945
3,948
4,058
4,009
3,425
1,873
1,492
1,413
LT Debt
289
75
421
83
-84
38
1,814
2,029
1,999
Total Equity
- -
- -
- -
- -
- -
2.53
4.21
11.01
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
2.13
3.5
12.36
- -
Return on Capital (%)
- -
-122.91
-56.65
-47.95
- -
- -
7.4
18.54
- -
Return on Common Equity (%)

Capital Structure

EUR

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
16
17
22
LT Borrowings
1,566
1,425
1,344
LT Finance Leases
69
67
69
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
199
199
199
Market Capitalization
3,823
3,791
3,771

Working Capital

EUR

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
765
760
802
Cash, Cash Equivalents & STI
341
274
285
Accounts Receivable, Net
301
323
370
Inventories
32
32
39
Total Current Liabilities
808
709
871
Payables & Accruals
- -
- -
- -
ST Debt
16
17
22
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
851.85%
11.82%
Free Cash Flow
- -
11.8%
6.23%
Net Income, GAAP
- -
116.18%
420.79%
Sales/Revenue/Turnover
- -
5.68%
4.29%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
1,847
2025
- -
- -
1,926
2026
- -
- -
- -

Semi-annual Earnings Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.34
2025
- -
- -
1.79
2026
- -
- -
- -

Semi-annual Dividends Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
0.13
2026
- -
- -
- -
Business
Springer Nature AG & Co. KGaA operates as a global research, health, educational, and professional publisher headquartered in Berlin, Germany, with a founding date tracing back to 1842 through its Springer imprint. The company publishes a comprehensive range of science, technology, engineering, mathematics, medical, and social sciences content via academic journals, books, monographs, textbooks, handbooks, reference works, and digital eBook formats under prominent brands including Nature, Springer, Palgrave Macmillan, and Adis. Its products and services encompass research journals, open access articles, scientific discovery platforms, research author services, medical education and pharmaceutical training materials, customized publishing content, specialist information services, and English language teaching and K12 educational curriculum materials, serving research and academic libraries, government agencies, healthcare sectors, and corporate clients worldwide. Recent major developments include the company’s milestone of publishing 50% of its primary research articles as open access by 2024, solidifying its leadership in open science and enhanced research accessibility. Springer Nature continues to invest heavily in technology and artificial intelligence, with a €177 million investment in 2024 to accelerate and improve the publishing process, including AI-based reviewer assistant tools and programs to detect fraudulent content. In the healthcare sector, it launched AskAdis, a conversational AI interface tailored for pharmaceutical markets. The company is also advancing sustainability by supporting the UN’s Sustainable Development Goals, targeting carbon neutrality, and organizing its publications around 17 SDG-related content hubs. Additionally, Springer Nature plans to go public on the Frankfurt Stock Exchange, aiming to enhance governance with a diverse supervisory board and implement a dividend policy reflecting strong cash flow generation. Operating across approximately 200 offices in 45 countries, Springer Nature is recognized as the world’s largest academic book publisher and a leading publisher of influential journals including the elite Nature portfolio. Its broad target markets include academic researchers, healthcare professionals, governmental research organizations, and educational institutions globally. Springer Nature is a subsidiary of GvH Vermögensverwaltungsgesellschaft Xxxiii mbH and is actively expanding its digital and AI-enabled publishing capabilities to support robust academic and scientific communication and research innovation worldwide.